More on PRTC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/28/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

PureTech Health Plc (NQ:PRTC)
Delayed: 16.80 -0.39 (2.27%)
Prev. Close $17.19  
Open$16.41 
52 Wk High$ 
52 Wk Low$ 
Day High$18.00 
Day Low$16.41 
P/E N/A  
EPS$ 
Volume3,728 

Friends, Peers and Foes (?): VOR, BAX, BMRN, BXLT, EMBC (more...)

Feb 25, 2026 02:00 AM PureTech to Present at the Leerink Partners Global Healthcare Conference
Feb 19, 2026 12:37 PM PureTech receives orphan drug designations for IPF treatment
Feb 19, 2026 12:36 PM PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
Jan 6, 2026 07:00 AM PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference
Dec 18, 2025 07:00 AM Form 6-K PureTech Health plc For: Dec 18
Dec 18, 2025 02:00 AM PureTech Health names Robert Lyne as permanent CEO
Dec 18, 2025 02:00 AM PureTech Appoints Robert Lyne as Chief Executive Officer
Dec 10, 2025 04:31 PM Form 6-K PureTech Health plc For: Dec 10
Dec 8, 2025 02:00 AM PureTech gets FDA feedback supporting phase 3 trial for lung drug
Dec 8, 2025 02:00 AM PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
View All Articles

Entities mentioned with PRTC

View All Entities